Health authorities in many countries recommend women planning pregnancy to take folic acid before and during pregnancy to reduce offspring risk of neural tube defects ([@bib15]). A large number of countries also fortify flour with folic acid ([@bib2]). Mandatory food fortification with folic acid is debated in some countries because of the suggested cancer risk in adults ([@bib6]; [@bib10]; [@bib16]). However, in case--control studies on children, cancer risks (leukemia, brain tumours) were reduced if the mother had been exposed to perigestational maternal folic acid supplementation ([@bib20]; [@bib13]; [@bib12]; [@bib11]). And, in ecological studies from Canada and the United States of America, the childhood cancer incidence (Wilms\' tumour, primitive neuroectodermal tumours, neuroblastoma) has been reduced after mandatory folic acid flour fortification ([@bib3]; [@bib4]; [@bib9]).

The aim of our study was to investigate the association between maternal intake of folic acid supplementation in pregnancy and offspring risk of childhood cancer in a nation-wide cohort study in Norway.

Materials and methods
=====================

Data sources
------------

The unique personal identification number assigned to all Norwegian residents enabled linkage of information between the Medical Birth Registry of Norway (MBRN) ([@bib5]), the Cancer Registry of Norway (CRN) ([@bib8]), and the Norwegian National Education Database that holds information on all individuals\' education ([@bib7]).

Folic acid and multivitamin supplementation exposure
----------------------------------------------------

Folic acid and multivitamin supplementation use has been registered in the MBRN since December 1998. The registration form uses check boxes with the items 'folic acid before pregnancy\', 'folic acid during pregnancy\', 'multivitamins before pregnancy\', and 'multivitamins during pregnancy\'. During the study period, the folic acid content was 0.4 mg in folic acid supplements and approximately 0.2 mg in multivitamin supplements. Children were defined as exposed to folic acid if their mothers used folic acid supplements and/or multivitamins before and/or during pregnancy. Maternal folic acid intake was categorised by increasing folic acid content; no supplement use (0 mg), only multivitamins (approximately 0.2 mg), only folic acid supplements (0.4 mg), or intake of both folic acid supplements and multivitamins (approximately 0.6 mg).

Childhood cancer
----------------

Childhood cancer cases were identified through linkage with CRN. For each child, the first cancer diagnosis was used. The childhood cancers were categorised according to the International Classification of Childhood Cancer, version 3, which is based on ICD-O-3 ([@bib18]).

Study cohort
------------

The study cohort consisted of all live births in Norway, 1 January 1999 through 31 December 2010 (excluding children with mothers with a prebirth cancer diagnosis (3371)), with follow-up until a cancer diagnosis, emigration, death, or 31 December 2010.

Statistical analysis
--------------------

Risk of childhood cancers in children exposed to maternal folic acid and/or multivitamin supplements was compared with cancer risk in unexposed children and estimated with hazard ratios (HRs) using Cox proportional hazards regression models with time since birth as the time variable, adjusting for *a priori* selected covariates associated with maternal folic acid use and childhood cancer risk; that is, birth order (1, 2, ⩾3), maternal smoking (never, sometimes, ⩽10 cigarettes daily, \>10 cigarettes daily, daily smoking of unknown amount), maternal and paternal age (\<25, 25--34, ⩾35 years), and maternal and paternal education (compulsory, intermediate, tertiary). *P*-values for linear trend were calculated for folic acid exposure levels (0 mg, 0.2 mg, 0.4 mg, 0.6 mg). Statistical analyses were performed in STATA version 14 ([@bib17]).

Ethics
------

The Regional Committee for Medical and Health Research Ethics of Western Norway approved the study.

Results
=======

Among 687 406 children included in the study, 799 developed cancer. The mean follow-up time was 6 years (range 0.04--12 years), constituting 4 052 679 person-years ([Table 1](#tbl1){ref-type="table"}). Among all births, 4% were multiple births, and 2% were born after assisted reproductive technology. Mean maternal age at childbirth was 29 years (range 13--55 years). The proportion of children exposed to perigestational supplementation increased in the study period, 1999--2010; intake of folic acid changed from 18% to 69% and multivitamins from 19% to 42%.

About 67% of all cancers were diagnosed within the first 3 years of life ([Table 2](#tbl2){ref-type="table"}). Leukemia and central nervous system (CNS) tumours accounted for 57% of the cases. We performed analyses for the six most frequent childhood cancer types (leukemia, lymphoma, CNS tumours, neuroblastoma, Wilms\' tumour, soft tissue tumours) ([Table 3](#tbl3){ref-type="table"}). There was no change in childhood leukemia risk by maternal use of multivitamins only (HR 1.23; 95% CI 0.75--2.01), folic acid use only (HR 1.13; 95% CI 0.79--1.63), or combined folic acid and multivitamin use (HR 1.25; 95% CI 0.89--1.76), as compared with no supplement use (*P*~Trend~ 0.20). Similarly, there were no associations between CNS tumours and different levels of maternal folic acid intake; multivitamins only (HR 1.08; 95% CI 0.60--1.94), folic acid use only (HR 1.18; 95% CI 0.78--1.78), or combined folic acid and multivitamin use (HR 0.68; 95% CI 0.42--1.10), as compared with no supplement use (*P*~Trend~ 0.32). The HRs of the other frequent childhood cancer types (lymphoma, neuroblastoma, Wilms\' tumour, soft tissue tumours) did not change for different levels of folic acid exposure. Adding birth year to adjustment models showed no substantial changes in the risk estimates for neither cancer types. And excluding 867 children with Down syndrome from the analyses did not change the HR estimates for specific cancers.

Discussion
==========

In a nation-wide cohort study of all live births, estimated maternal intakes of multivitamins, folic acid, or combined intake of these supplements were not associated with childhood cancer.

Our results of no association between periconceptional folic acid supplementation and major childhood cancers are in discordance with case--control studies showing inverse associations between self-reported folic acid use and acute lymphoblastic leukemia (ALL) ([@bib20]; [@bib13]; [@bib11]) and CNS tumours ([@bib12]).

A recent large international collaborating study, including \>7000 children with acute leukemia and 11 000 controls, found reduced risks of ALL and acute myeloid leukemia (AML) after maternal intake of folic acid supplements. And these reduced risks of ALL and AML did not vary by timing of the supplementation exposure (preconception, pregnancy, or pregnancy trimester) ([@bib11]). However, an Australian study found weak evidence of a reduced risk of ALL from folate supplementation before pregnancy, but no reduced risk from use during pregnancy ([@bib13]). Also, another Australian study reported on an inverse association of childhood brain tumours and folic acid supplementation before and possibly also during pregnancy ([@bib12]). In our study, a further stratification of the exposure data into preconceptional use and use during pregnancy was not feasable due to the limited statistical power of the analyses.

The strengths of our study include using comprehensive data from population-based registries covering the entire Norwegian population. To our knowledge, Norway is the only country where individual-level information on periconceptional folic acid and multivitamin intake has been collected for the entire birth population since 1999. All incident cancer cases have been reported to the Cancer Registry of Norway since 1952 ([@bib8]). And information on supplement use was collected before cancer diagnosis precluding recall bias.

The study had some limitations. Even though our cohort was large, the numbers of several childhood cancer types were relatively low, which may limit the statistical power of our findings. The follow-up time of study participants were on average 6 years, and our results could only be generalised to younger children. Maternal folic acid intake could have been misclassified; in the beginning of the study period, folic acid users were under-reported to the MBRN ([@bib14]). A possible misclassification of folic acid dose (independent of cancer risk) would bias risk estimates towards the null value and, in theory, could have concealed an association between folic acid intake and childhood cancer risk. Information on maternal smoking was missing for 16% of the births; however, HR estimates adjusting for maternal smoking were similar to HRs without smoking adjustments. Although we did not have information on dietary folate, residual confounding by dietary folate is less likely. In pregnant women, maternal plasma levels of serum folate is strongly related to intake of folic acid supplements ([@bib1]). And in other studies of maternal intake of folic acid supplements and offspring outcomes (oral clefts, autism), adjustment for dietary folate did not change overall risk estimates ([@bib21]; [@bib19]). We could not adjust for mother\'s weight and height, physical activity, diet, use of alcohol, or use of contraceptive pills, as these covariates were not available in the MBRN.

In conclusion, we found no association between maternal supplemental folic acid intake before and/or during pregnancy and risk of leukemia, lymphomas, CNS tumours, neuroblastoma, Wilms\' tumour, or soft tissue tumours among younger children.
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###### Characteristics of the study population of 687 406 live births, Norway, 1999--2010

  **Characteristics**                                        **Cohort (*****n***)   **Person-years**   **%**   **Cancer cases (*****n***)
  --------------------------------------------------------- ---------------------- ------------------ ------- ----------------------------
  Children                                                         687 406             4 052 679        100               799
  **Sex**                                                                                                     
  Boys                                                             352 604             2 077 322        51                423
  Girls                                                            334 802             1 975 357        49                376
  **Gestational age (weeks)**                                                                                 
  \<37                                                              46 682              271 770          7                 60
  37--41                                                           587 197             3 447 416        85                670
  ⩾42                                                               48 830              307 613          8                 62
  Missing                                                            4697                25 881          1                 7
  **Birth weight (g)**                                                                                        
  \<2500                                                            33 804              191 809          5                 39
  2500--3999                                                       516 075             3 008 163        74                587
  ⩾4000                                                            136 760              847 264         21                173
  Missing                                                            767                  5443           0                 0
  **Birth order**                                                                                             
  1                                                                284 468             1 651 442        41                339
  2                                                                244 834             1 446 964        36                281
  ⩾3                                                               158 104              954 274         24                179
  **Maternal age at child birth, years**                                                                      
  \<25                                                             117 065              697 604         17                133
  25--34                                                           452 481             2 709 049        67                539
  ⩾35                                                              117 860              646 026         16                127
  **Paternal age at child birth, years**                                                                      
  \<25                                                              52 776              312 202          8                 65
  25--34                                                           396 496             2 406 027        59                468
  ⩾35                                                              231 836             1 307 428        32                257
  Missing                                                            6298                27 023          1                 9
  **Maternal education**[a](#t1-fn1){ref-type="fn"}                                                           
  Compulsory                                                       128 452              782 418         19                148
  Intermediate                                                     232 745             1 475 123        36                288
  Tertiary                                                         299 871             1 662 622        41                340
  Missing                                                           26 338              132 516          3                 23
  **Paternal education**[a](#t1-fn1){ref-type="fn"}                                                           
  Compulsory                                                       129 537              779 208         19                142
  Intermediate                                                     301 918             1 842 424        45                373
  Tertiary                                                         227 910             1 297 762        32                251
  Missing                                                           28 041              133 286          3                 33
  **Maternal smoking**                                                                                        
  Did not smoke                                                    459 617             2 678 139        66                529
  Smoked sometimes                                                  17 222              106 380          3                 15
  Smoked ⩽10 cigarettes daily                                       69 270              455 935         11                103
  Smoked \>10 cigarettes daily                                      25 210              144 005          4                 30
  Smoked daily, unknown amount                                       5331                33 502          1                 4
  Missing                                                          110 756              634 718         16                118
  **Maternal supplementation**[b](#t1-fn2){ref-type="fn"}                                                     
  No use                                                           325 706             2 307 683        57                424
  Multivitamins only                                                46 598              309 597          8                 61
  Folic acid only                                                  145 856              675 461         17                154
  Folic acid and multivitamin use                                  169 246              759 938         19                160

Compulsory education length was 9 years until 1996 and 10 years from 1997 onwards.

Maternal supplement intake before and/or during pregnancy, categorised by folic acid content: No use; multivitamins (approximately 0.2 mg); folic acid supplements (0.4 mg); and folic acid and multivitamins (approximately 0.6 mg).

###### Children with first-time childhood cancer (*n*=799) by age at diagnosis, year of diagnosis, and major cancer types (ICCC-3), identified among 687 406 livebirths, Norway, 1999--2010

                                                                            **Cancer cases**   **%**
  ------------------------------------------------------------------------ ------------------ -------
  **Age at cancer diagnosis (years)**                                                         
  \<2                                                                             326           41
  2--3                                                                            211           26
  4--5                                                                            150           19
  ⩾6                                                                              112           14
  **Year of cancer diagnosis**                                                                
  1999--2001                                                                       59            7
  2002--2004                                                                      172           22
  2005--2007                                                                      239           30
  2008--2010                                                                      329           41
  **Cancer types (ICCC-3)**                                                                   
  I Leukemias, myeloproliferative diseases, and myelodysplastic diseases          268           34
   Lymphoid leukemia                                                              208             
   Acute myeloid leukemias                                                         45             
  II Lymphomas and reticuloendothelial neoplasms                                   42            5
  III CNS and miscellaneous intracranial and intraspinal neoplasms                185           23
   Ependymoma                                                                      26             
   Astrocytoma                                                                     79             
   Intracranial and intraspinal embryonal tumours                                  50             
  IV Neuroblastoma and other peripheral nervous cell tumours                       72            9
   Neuroblastoma and ganglioneuroblastoma                                          71             
  VI Renal tumours                                                                 53            7
   Wilms\' tumour                                                                  52             
  IX Soft tissue and other extraosseous sarcomas                                   64            8
   Rhabdomyosarcoma                                                                24             
   Other specified soft tissue sarcomas                                            28             
  Other cancers                                                                   115           14
  Total                                                                           799           100

Abbreviations: CNS=central nervous system; ICCC-3=International Classification of Childhood Cancer, third edition ([@bib18]).

###### Hazard ratios (HRs) with 95% confidence intervals (95% CI) of childhood cancer by perigestational supplementation of folic acid and/or multivitamins, among 687 406 children, Norway, 1999--2010

  **Cancer types**                                                             **Supplements**[a](#t3-fn2){ref-type="fn"}    **Cancer cases**   **HR**[b](#t3-fn3){ref-type="fn"}   **95% CI**   ***P***~**Trend**~
  ---------------------------------------------------------------------------- -------------------------------------------- ------------------ ----------------------------------- ------------ --------------------
  All cancers                                                                  No supplements                                      424                        1.00                  Reference             
                                                                               Multivitamins only                                   61                        1.05                  0.78--1.42            
                                                                               Folic acid only                                     154                        1.13                  0.92--1.38            
                                                                               Folic acid and multivitamins                        160                        1.02                  0.83--1.25          0.60
  **I Leukemias, myeloproliferative diseases, and myelodysplastic diseases**                                                                                                                    
                                                                               No supplements                                      135                        1.00                  Reference             
                                                                               Multivitamins only                                   21                        1.23                  0.75--2.01            
                                                                               Folic acid only                                      50                        1.13                  0.79--1.63            
                                                                               Folic acid and multivitamins                         62                        1.25                  0.89--1.76          0.20
  **(a) Lymphoid leukemia**                                                                                                                                                                               
                                                                               No supplements                                      100                        1.00                  Reference             
                                                                               Multivitamins only                                   16                        1.30                  0.75--2.27            
                                                                               Folic acid only                                      42                        1.30                  0.87--1.95            
                                                                               Folic acid and multivitamins                         50                        1.31                  0.89--1.94          0.12
  **(b) Acute myeloid leukemia**                                                                                                                                                                          
                                                                               No supplements                                       28                        1.00                  Reference             
                                                                               Multivitamins only                                   3                         0.97                  0.29--3.27            
                                                                               Folic acid only                                      5                         0.59                  0.22--1.60            
                                                                               Folic acid and multivitamins                         9                         0.96                  0.43--2.17          0.67
  **II Lymphomas and reticuloendothelial neoplasms**                                                                                                                                            
                                                                               No supplements                                       25                        1.00                  Reference             
                                                                               Multivitamins only                                   3                         0.55                  0.13--2.33            
                                                                               Folic acid only                                      5                         0.40                  0.12--1.34            
                                                                               Folic acid and multivitamins                         9                         0.96                  0.42--2.21          0.51
  **III CNS and miscellaneous intracranial and intraspinal neoplasms**                                                                                                                          
                                                                               No supplements                                      107                        1.00                  Reference             
                                                                               Multivitamins only                                   14                        1.08                  0.60--1.94            
                                                                               Folic acid only                                      37                        1.18                  0.78--1.78            
                                                                               Folic acid and multivitamins                         27                        0.68                  0.42--1.10          0.32
  **(b) Astrocytoma**                                                                                                                                                                                     
                                                                               No supplements                                       44                        1.00                  Reference             
                                                                               Multivitamins only                                   8                         1.57                  0.72--3.40            
                                                                               Folic acid only                                      15                        1.31                  0.70--2.45            
                                                                               Folic acid and multivitamins                         12                        0.86                  0.43--1.73          0.97
  **(c) Intracranial and intraspinal embryonal tumours**                                                                                                                                                  
                                                                               No supplements                                       28                        1.00                  Reference             
                                                                               Multivitamins only                                   2                         0.61                  0.14--2.59            
                                                                               Folic acid only                                      12                        1.28                  0.60--2.76            
                                                                               Folic acid and multivitamins                         8                         0.69                  0.27--1.74          0.69
  **IV Neuroblastoma and other peripheral nervous cell tumours**                                                                                                                                
  **(a) Neuroblastoma and ganglioneuroblastoma**                                                                                                                                                          
                                                                               No supplements                                       37                        1.00                  Reference             
                                                                               Multivitamins only                                   5                         0.99                  0.35--2.82            
                                                                               Folic acid only                                      15                        1.08                  0.54--2.15            
                                                                               Folic acid and multivitamins                         14                        1.05                  0.53--2.06          0.85
  **VI Renal tumours**                                                                                                                                                                          
  **(a) Wilms\' tumour**                                                                                                                                                                                  
                                                                               No supplements                                       28                        1.00                  Reference             
                                                                               Multivitamins only                                   5                         1.60                  0.60--4.25            
                                                                               Folic acid only                                      9                         1.01                  0.42--2.40            
                                                                               Folic acid and multivitamins                         10                        1.16                  0.52--2.58          0.76
  **IX Soft tissue and other extraosseous sarcomas**                                                                                                                                            
                                                                               No supplements                                       32                        1.00                  Reference             
                                                                               Multivitamins only                                   5                         1.12                  0.39--3.22            
                                                                               Folic acid only                                      18                        1.72                  0.90--3.29            
                                                                               Folic acid and multivitamins                         9                         0.77                  0.34--1.75          0.90

Abbreviation: CNS=central nervous system.

Maternal supplement intake before and/or during pregnancy, categorised by folic acid content: No use; multivitamins (approximately 0.2 mg); folic acid supplements (0.4 mg); and folic acid and multivitamins (approximately 0.6 mg).

Hazard ratios (HR) with 95% confidence intervals (95% CI) adjusted for birth order (1, 2, ⩾3), smoking (never, sometimes, ⩽10 cigarettes daily, \>10 cigarettes daily, daily smoking of unknown amount), maternal and paternal age (\<25, 25--34, ⩾35 years), and maternal and paternal education (compulsory, intermediate, tertiary) comparing cancer risk in children exposed to periconceptional folic acid (multivitamins, folic acid, folic acid and multivitamins) and cancer risk in children without perigestational folic acid exposure (reference).
